promising tki-ici combinations for non-clear cell rcc
Published 1 year ago • 42 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
-
1:49
using combination therapy as treatment of non-clear cell rcc
-
11:18
first-line icis in advanced non-clear cell rcc
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
3:15
a novel approach: tki/i-o combinations in rcc
-
1:17
treating non-clear cell renal cell carcinoma patients
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
1:16
new tools for rcc treatment
-
0:53
unanswered questions in the management of clear cell rcc
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
1:40
dr. choueiri on checkpoint inhibitor/tki combinations in rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
12:16
non clear-cell type rcc
-
5:12
renal cell carcinoma trial analysis: current landscape of immunotherapy combinations